NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
47 hedge funds and large institutions have $6.25M invested in Nymox Pharmaceutical Corp in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
59% less call options, than puts
Call options by funds: $123K | Put options by funds: $300K
Holders
47
Holding in Top 10
–
Calls
$123K
Puts
$300K
Top Buyers
| 1 | +$110K | |
| 2 | +$49K | |
| 3 | +$34K | |
| 4 |
JP Morgan Chase
New York
|
+$24.1K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$17.3K |
Top Sellers
| 1 | -$295K | |
| 2 | -$206K | |
| 3 | -$52.1K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$39.8K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$39.5K |